"10.1371_journal.pone.0107165","plos one","2014-09-08T00:00:00Z","Yvonne MÃ¶ller; Martin Siegemund; Sven Beyes; Ricarda Herr; Daniele Lecis; Domenico Delia; Roland Kontermann; Tilman Brummer; Klaus Pfizenmaier; Monilola A Olayioye","Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany; Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; Centre for Biological Signalling Studies BIOSS, Albert-Ludwigs-University of Freiburg, Freiburg, Germany; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","Conceived and designed the experiments: YM MS SB RK TB KP MAO. Performed the experiments: YM SB MS RH. Analyzed the data: YM SB MAO. Contributed reagents/materials/analysis tools: MS RH DL DD RK TB KP. Contributed to the writing of the manuscript: YM TB KP MAO.","DL and DD are inventors on the patent WO/2013/124701 (PCT/IB2012/000297: â€˜Homo- and heterodimeric smac mimetic compounds as apoptosis inducersâ€™). KP and RK and MS are inventors on the patent CA2831820 A1 (PCT/EP2012/001426: â€˜Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereofâ€™). KP is a consultant and has received commercial research funding from SME. RK is a consultant and has received commercial research funding from BioNTech. The authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials.","2014","09","Yvonne MÃ¶ller","YMÃ",10,TRUE,7,4,3,NA,TRUE,TRUE,FALSE,0,NA,FALSE
